Pre-publication history
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
-
* Corresponding author: Blas Y Betancourt blas.yamir@cigb.edu.cu
BMC Clinical Pharmacology 2005, 5:5 doi:10.1186/1472-6904-5-5
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 05 Mar 2005 | |
| Reviewer's Report | peter sleight | 27 Jun 2005 | |
| Reviewer's Report | Munir Pirmohamed | 24 Jul 2005 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 01 Sep 2005 |
| Reviewer's Report | Munir Pirmohamed | 04 Oct 2005 | |
| Reviewer's Report | peter sleight | 07 Oct 2005 | |
| Resubmission - Version 3 | Manuscript | 09 Oct 2005 | |
| Resubmission - Version 4 | Manuscript | 31 Oct 2005 | |
| Published | 02 Nov 2005 |